Abattis receives Intl Class 5 Trademark for DefenZall in the U.S. and Taiwan

Published on January 17, 2013 at 4:06 AM · No Comments

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CNSX: FLU), announces it has been granted Intl Class 5 Trademark for DefenZall™ in Taiwan and the USA.

Mr. Mike Withrow , Chief Executive Officer on behalf of the Company, stated, "We are pleased to extend the intellectual property of the company as we grow our brands. This mark will be used to brand our proprietary Anti-Viral Nutraceutical Platform of products which are; DefenZall Daily™, DefenZall Immune Support™ and DefenZall Serious Defense™ They will be launched through our Canadian distributor Hedley Enterprises, on the Internet and via our Distributor in Hong Kong."

Source:

Abattis Bioceuticals Corp.

Posted in: Disease/Infection News | Pharmaceutical News

Tags: , , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Two randomized trials examine new vaccination strategies for avian influenza